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Abstract 
Background: ICON® Maxx (Syngenta) is an insecticide treatment kit of pyrethroid and binding agent for long-lasting 
treatment of mosquito nets. Interim recommendation for use on nets was granted by the World Health Organization 
(WHO) after successful evaluation in experimental huts following multiple washes. A full WHO recommendation is 
contingent upon demonstration of continued bio-efficacy after 3 years of use.
Methods: A household-randomized prospective study design was used to assess ICON Maxx-treated nets over 
3 years in north-eastern Tanzania. Conventional treated nets (with lambda-cyhalothrin, but without binder) served as 
a positive control. At 6-monthly intervals, cross-sectional household surveys monitored net use and physical integrity, 
while cone and tunnel tests assessed insecticidal efficacy. Pyrethroid content was determined after 12 and 36 months. 
A parallel cohort of nets was monitored annually for evidence of net deterioration and attrition.
Results: After 12 months’ use, 97% of ICON Maxx-treated nets but only 67% of CTN passed the WHO efficacy thresh-
old for insecticidal durability (> 80% mortality in cone or tunnel or 90% feeding inhibition in tunnel). After 24- and 
36-months use, 67% and 26% of ICON Maxx treated nets met the cone criteria, respectively, and over 90% met the 
combined cone and tunnel criteria. Lambda-cyhalothrin content after 36 months was 17% (15.8 ± 4.3 mg/m2) of 
initial content. ICON Maxx nets were used year-round and washed approximately 4 times per year. In cross-sectional 
survey after 36 months the average number of holes was 20 and hole index was 740  cm2 per net. Cohort nets had 
fewer holes and smaller hole index than cross-sectional nets. However, only 15% (40/264) of cohort nets were not lost 
to follow-up or not worn out after 36 months.
Conclusions: Because more than 80% of nets met the WHO efficacy criteria after 36 months use, ICON Maxx was 
granted WHO full recommendation. Cross-sectional and cohort surveys were complementary and gave a fuller under-
standing of net durability. To improve net usage and retention, stronger incentives and health messaging should be 
introduced in WHO LLIN longitudinal trials. Untreated polyester nets may be made long-lastingly insecticidal in Africa 
through simple household treatment using ICON Maxx pyrethroid-binder kits.
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Background
Long-lasting insecticidal nets (LLINs) are an important 
tool for malaria vector control. With LLIN technology, 
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Anopheline mosquitoes for at least 3  years without 
need for further retreatment [1]. The proportion of 
the population with access to insecticide-treated nets 
(ITNs) and LLINs has increased markedly in sub-Saha-
ran Africa over the past two decades. Manufacturers’ 
delivery data for 2004–2020 show that over 2.3 billion 
ITNs and LLINs were supplied globally in that period, 
of which 1.9 billion (86%) were supplied to sub-Saharan 
Africa [2]. By 2019, 68% of households in Africa had 
at least one ITN/LLIN, increasing from about 5% of 
households in 2000. The percentage of the population 
sleeping under ITNs or LLINs has increased from less 
than 2% in 2000 to 46% in 2019 [2]. Although highest 
numbers of LLINs are being delivered to sub-Saharan 
countries, 1 in 4 children live in households with no 
access to ITN or protection by indoor residual spray-
ing [3]. To achieve one LLIN for every two household 
members, a ratio considered sufficient to achieve uni-
versal coverage [4], an estimated 200–300 million 
replacement nets are required each year to achieve and 
maintain universal access [3].
Owing to the insufficient number of LLINs being deliv-
ered through NMCPs and NGOs, many households use 
nets sourced locally through commercial and retail sec-
tors. The majority of these are not LLINs and surveys 
show most have either never been treated or were treated 
only once on purchase [5–7]. These nets may be made 
from a variety of synthetic polymers or natural fibres. 
This emphasizes the need for long-lasting insecticide 
treatment kits that can be used to convert untreated nets 
into products that withstand repeated washing with-
out need for annual retreatment. Such insecticide kits 
could be bundled together with untreated nets, sold from 
shops, and enable local net producers that lack LLIN 
manufacturing technology to produce a long-lasting ITN, 
which could address local LLIN shortages and contribute 
usefully to malaria control [1, 3].
Two brands of long-lasting treatment kit have been 
developed: KO-Tab 123 by Bayer Environmental Sci-
ences [8] and ICON Maxx by Syngenta [9]. KO-Tab 123 
treated nets remained insecticidal for 15–20 washes 
in WHO Phase II evaluation trials [8]. ICON Maxx is a 
twin-sachet treatment kit for treatment of individual 
family-sized polyester nets based on a slow-release cap-
sule suspension formulation of lambda-cyhalothrin 10% 
CS and binding agent. Following bio-efficacy and wash-
fastness studies in Phase I laboratory and Phase II experi-
mental hut studies in Tanzania and Burkina Faso, WHO 
interim recommendation was granted to ICON Maxx 
[9, 10]. Further hut trials were run in Côte d’Ivoire [11]. 
Full WHO recommendation is only granted after dem-
onstrating the candidate LLIN or long-lasting treatment 
kit meets specific efficacy criteria after 3 years of regular 
household use in large scale Phase III longitudinal trials 
[12, 13].
The main objective of the present study was to evalu-
ate ICON Maxx treated nets in line with WHO guide-
lines for field testing of LLIN to determine insecticidal 
efficacy, wash fastness, acceptability, net integrity and 
net survivorship under East African household condi-
tions over 3 years of use in comparison with a standard 
lambda-cyhalothrin 10% CS conventionally treated net 
without binder. Running in parallel with this Phase III 
longitudinal study presented here, a series of Phase I lab-
oratory studies with ICON Maxx were run on a variety of 
polymer netting materials (polyethylene, polyester, nylon, 
cotton) to assess the treatment kit’s versatility on other 
types of netting and household substrates.
Methods
Study areas
The trial was conducted in the two coastal villages, Ton-
goni and Mwarongo, in Muheza and Tanga districts 
(5°10′ 0S; 38°46′ 0E) (Fig.  1). In the household demo-
graphic census survey, Tongoni village comprised 5 
hamlets and 484 houses, Mwarongo village comprised 
2 hamlets and 335 houses. The residents subsisted on 
maize, cassava and rice with some working on sisal plan-
tations and others on orange plantations and animal hus-
bandry. Annual rainfall was bimodal: short rains from 
October to December, long rains from March to June, 
ranging from 800–1400  mm per annum. Malaria trans-
mission occurred most of the year, and there were two 
seasonal mosquito peaks during and after the long and 
short rainy seasons [14, 15]. During the rains Anopheles 
gambiae sensu stricto (s.s.) predominated, and in the dry 
season Anopheles funestus was more common. Malaria 
transmission is classified as holoendemic although some 
areas of the districts have a long history of ITN use [14, 
16] and LLIN universal coverage campaigns took place in 
2011 [7].
Study design
The efficacy of ICON Maxx (Syngenta, Switzerland) 
treated polyester nets and nets conventionally treated 
with lambda-cyhalothrin CS (Iconet CS, Syngenta, 
Switzerland) at WHO recommended dosages were 
compared under field conditions in a two-arm house-
hold randomized trial with the household as the unit of 
randomization and mosquito nets as the unit of obser-
vation. The conventionally treated nets (CTN) were 
studied for one year after which all households with the 
Iconet-treated CTN were replaced with ICON Maxx 
treated nets [12]. The efficacy of ICON Maxx treated 
nets were monitored for up to 3  years of continuous 
use. It should be noted that the study coincided with 
Page 3 of 17Tungu et al. Malar J          (2021) 20:345  
the publishing of the 2013 revised WHO Guidelines 
for Laboratory and Field Testing of LLIN which recom-
mended that a candidate LLIN or long-lasting treat-
ment kit should be field evaluated with reference to an 
existing WHO-recommended LLIN rather than a CTN 
[13]. The WHO made an exception for Phase III trials 
already in progress.
Seven cross sectional surveys were undertaken, the 
first was carried out 1  month after net distribution, 
subsequent surveys took place every 6 months. A ran-
dom sample of 30–50 households from each arm was 
selected every 6  months from the master list of par-
ticipating households and subjected to physical integ-
rity inspection, cone bioassay and tunnel tests. In year 
1, both arms were surveyed, in years 2 and 3 only the 
ICON Maxx arm was surveyed.
Additional cohorts of 250 nets from a randomly 
selected 100 households from each arm were followed 
up annually for 3 years in the case of ICON Maxx and 
for 1  year in the case of Iconet CTN for assessment 
of survivorship and attrition in accordance with the 
revised WHO guideline [13].
Treatment of nets with ICON Maxx and Iconet
A total of 2500 polyester nets were treated individually 
with long-lasting ICON Maxx (Syngenta, Switzerland) 
from twin sachet packs, containing 7.3  ml of lambda-
cyhalothrin 10% CS and 7.7  ml of binding agent. Nets 
were available in three widths (180, 150 and 120  cm) 
according to family needs and sleeping arrangements and 
were all 180 cm long and 150 cm high. ICON Maxx solu-
tion was applied by hand individually in basins according 
to the manufacturer’s instructions using the appropriate 
volume of solution for each size of net to give a target 
dose of 62 mg AI/m2. A safety assessment concluded that 
no unacceptable exposures were found in the prepara-
tion, maintenance and use of the nets over the prescribed 
dose range of 50 (for family net) to 83 (for single net) mg 
AI/m2 [9].
A further 1250 conventionally treated polyester nets 
were treated with lambda-cyhalothrin 10% CS sachet 
(Iconet 10% CS, Syngenta Switzerland) without binder to 
a recommended target dose of 15  mg AI/m2 [8]. Treat-
ment of nets was carried out by a trained team of field 
workers under supervision of the principal investigator. 
Fig. 1 The Map of Tanzania (top left), Muheza district (middle) and the GPS-generated map of study area showing hamlet boundaries
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During treatment field workers wore personal protec-
tive clothing including gloves and masks. Treatment 
was done outdoors in the open air and nets were dried 
on plastic sheeting under shade. Nets were turned over 
periodically until dripping stopped and then hung-over 
washing lines to complete the drying.
Household randomization and net distribution
Houses were numbered during a village and household 
census. After the census, the ICON Maxx nets and CTNs 
were distributed to each household door-to-door in late 
June and early July 2011. A total of 1250 ICON Maxx nets 
and 1250 CTNs were distributed. A further 1250 ICON 
Maxx nets were held back to replace the 1250 CTNs at 
the end of the first year. The distribution was stratified by 
household so that each net type was present in each ham-
let in a 1:1 ratio. Individual households received either 
ICON Maxx or Iconet CTNs rather than a mix of types. 
A unique code number was written on each net using 
a permanent marker. Sufficient nets were distributed 
to cover all sleeping spaces in each house. Household-
ers were informed about the need for reporting adverse 
effects during net use and advised on proper use and 
maintenance. Assistance in hanging nets over the sleep-
ing places was given where needed.
Household surveys and net integrity (cross‑sectional 
surveys)
During cross-sectional household surveys nets were sam-
pled from each treatment arm at six-monthly intervals. 
Both ICON Maxx and CTNs were randomly sampled at 
6 and 12 months after distribution; thereafter, only ICON 
Maxx nets were sampled after 18, 24, 30 and 36 months 
of use. The 30 households sampled per survey (50 in the 
final 36-month survey) were selected at random using the 
household ID master list, one net from each household 
was sampled, the selected household received a replace-
ment ICON Maxx net and then removed from the study. 
At the time of each cross-sectional survey and net col-
lection, a household questionnaire was applied to assess 
net use, acceptability, washing practices and any adverse 
effects.
Net integrity surveys were carried out every 6 months 
for 36  months in the randomly selected ICON Maxx 
houses and after 6 and 12  months in the randomly 
selected CTN houses. Each selected net was hung over 
a wooden frame and scored for size and distribution of 
holes, repairs (stitches, knots and patches) and open/
failed seams. Assessment of cleanliness was done concur-
rently and nets categorized according to their degree of 
dirtiness. Hole sizes were categorized as size 1—smaller 
than a thumb, size 2—larger than a thumb but smaller 
than a fist, size 3—larger than a fist but smaller than 
a head, size 4—larger than a head. Hole index was esti-
mated using the method defined by the WHO, which 
assumes that the hole size equates to the mid-point of 
the range for each hole size category [13]. The estimate 
of hole area gives a slightly more conservative value when 
compared to the hole index [17].
Net attrition and functional survivorship (cohort surveys)
Two cohorts of 100 houses from ICON Maxx and Iconet 
CTN arm were selected, censused and nets checked at 
the end of each study year (after 12, 24 and 36 months) 
for condition, attrition and functional survivorship. Study 
nets were recorded as present, discarded due to damage 
(wear and tear, rodent and burn holes) or lost to follow 
up. Households where the inhabitants were absent or 
where nets were recorded as given away, used elsewhere, 
stolen or lost were not included in the estimates of func-
tional survivorship. Functional net survivorship was 
based on damage only and did not include in numera-
tor or denominator nets lost to follow up due to family 
movement, theft, gifted or sold as these nets might still 
be functional.
Chemical analysis
From each of the ICON Maxx and CTN sampled at 
baseline and surveyed at 12, 24, 30 and 36 months, five 
additional pieces of netting (30 cm × 30 cm) were cut for 
chemical analysis from each of the five panels of each 
net. The piece closest to the mattress line was excluded 
as per WHO guidelines [12]. All pieces were sent to the 
WHO-collaborating at the Centre Wallon de Recherches 
Agronomiques (CRA-W) for chemical analysis. The net 
pieces from each net were pooled, cut into small pieces 
and homogenized, and lambda-cyhalothrin was extracted 
and quantified using gas chromatography CIPAC 463/
LN/M/3 [18].
Bio‑efficacy and residual activity of nets
From the 30 to 50 ICON Max nets and CTNs sam-
pled every 6  months, 5 netting pieces measuring 
25 cm × 25 cm were cut from the five panels of each net 
in accordance with WHO guidelines [12]. Cone bioassay 
tests were carried out on the netting pieces at the NIMR 
Amani Centre using 2–5 day old, unfed, female An. gam-
biae s.s. (Kisumu). Twenty mosquitoes were exposed in 4 
replicates of 5 mosquitoes to pieces from positions 2–5 
of each net (total of 80 mosquitoes per net) for 3 min in 
WHO plastic cones; the piece where abrasion was great-
est (tucked under the mattress) was excluded as recom-
mended by WHO [12]. After exposure the mosquitoes 
were held in paper cups at 26 °C and 80% relative humid-
ity and given access to 10% glucose solution. Knockdown 
was recorded 1 h after exposure and mortality after 24 h. 
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When knockdown was < 95% and mortality was < 80%, 
the net was subjected to tunnel testing [12]. The net piece 
closest to average mortality of the net was tested in the 
tunnel. Any net meeting the cone criteria of ≥ 80% mor-
tality or ≥ 95% knockdown or tunnel test criteria of ≥ 80% 
mortality or ≥ 90% blood-feeding inhibition was consid-
ered to have met the required threshold.
Data analysis
Data were double-entered into Microsoft Access and 
analysed in STATA version 10. Comparison of chemical 
content between net types over time was analysed using 
analysis of variance and t-tests. Wilcoxon rank sum test 
was used to analyse continuous data that was not nor-
mally distributed. Logistic regression was used to analyse 
the association between percentage knockdown and 24-h 
mortality with washing, net usage and insecticide con-
tent. Chi-squared test for trend was used to analyse net 
efficacy over successive surveys. Poisson regression was 
used to the test for association between hole index and 
time, number of washes and net usage.
Ethics, consent and permission
Ethical clearance was obtained from the ethics commit-
tees of the NIMR Tanzania (Ref: NIMR/HQ/R.8a/Vol 
X/86) and London School of Hygiene and Tropical Medi-
cine. Written informed consent was obtained from all 
household heads of participating families.
Results
Household surveys
A total of 705 households were identified in the base-
line survey; 70% had mud walls and 75% palm thatched 
roofs. Other roofing materials included corrugated iron, 
some walls were made of brick. The mean ages of house-
hold heads in ICON Maxx and Iconet households were 
43 and 52  years respectively. Most householders were 
farmers (33% ICON Maxx, 55% Iconet); the remainder 
were employed as fishermen, teachers, nurses, students 
or unemployed. The majority (65% ICON Maxx, 78% 
Iconet) had received 7 years of primary school education, 
7% and 20% had received secondary education and others 
had not gone to school at all.
Both the ICON Maxx nets and Iconet CTNs were 
well-accepted by the communities. Reported net use was 
100%. Respondents indicated using their nets year-round 
and every night. Almost 90% of surveyed nets were found 
hanging above beds and 10% were observed suspended 
over floor mattresses. 72% and 78% of sampled popula-
tions stated their reason for using nets was to protect 
themselves from mosquito biting while 13% and 28% 
stated for protection from malaria. The frequency of net 
washing was found not to differ between ICON Maxx net 
surveys. Estimated washing frequency was 4 times per 
year (Table 1).
All respondents in all surveys reported washing their 
nets in cold water. Nobody reported rubbing nets against 
rocks or on washing stones. Nets were pre-soaked by 
18–40% of respondents; soaking times ranged from 
10  min to 4  h. Nets were reported washed using com-
mercial bar soap (30–85%), detergent powder (14–50%) 
or both (14–32%). Most nets (92–98%) were rinsed after 
washing and most (92–98%) were dried outdoors.
Despite householders reporting high frequency of 
ICON Maxx net washing, it was observed that only 
45% and 16% were scored as clean at 12  months and 
36  months respectively and 19% and 22% were scored 
as very dirty at 24  months and 36  months respectively. 
There was no association between the alpha-cyperme-
thrin content remaining on the nets at 36  months and 
the reported number of washes  (F1,48 = 1.2, P = 0.30). Nor 
was there any association between the reported number 
of washes over 36 months and the proportion of nets fail-
ing the cone bioassay criterion  (F1, 48 = 0.3, P = 0.85).
Physical integrity of nets in cross‑sectional surveys
The same brand of 100-denier nets was used in ICON 
Maxx and Iconet CTN arms. In the baseline survey there 
were no holes or open seams on any of the sampled nets 
in the ICON Maxx or CTN arms. After 6 months, approx-
imately half of the nets (52% of ICON Maxx nets, 56% of 
Iconet CTNs) had at least one hole (these were mainly of 
the smallest size category) (Table  3); the mean number 
of holes per net was 4.3 for ICON Maxx nets and 5.5 for 
CTN (Table 2). The number of holes increased between 
6 and 12 months to a mean of 9 for ICON Maxx arm and 
7 for Iconet arm; the majority of holes were always found 
in the lower part of the panels (Table 3). Comparison of 
physical integrity between ICON Maxx and CTN nets 
confirmed there was no difference between either arm 
at 12 months when the CTNs were disused (Tables 2, 3). 
After 24 months, while most ICON Maxx nets (84%) had 
a least one hole, these remained of the smallest hole cat-
egory (Tables 2, 3); the mean number of holes per net had 
increased to 14.5 (Tables 2, 3), the mean hole index (HI) 
was 589, the median HI was 197 (IQR = 352) and the geo-
metric mean number was 71 (Table 4). After 36 months, 
most hole indices had increased: 82% of nets were holed 
(Tables 2, 3), the majority were still size 1 (59%), the mean 
HI was 740, the median HI was 417 (IQR = 615) and the 
geometric mean number was 59 (Table 4).  
The age of nets (number of months of use) was posi-
tively associated with net HI  (F1,345 = 9.31, P = 0.002). 
There was no association between the reported number 
of washes per net and net HI  (R2 = 0.015, P < 0.4027), 
suggesting that frequency of reported washing was not 
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associated with net durability. Nor did any differences in 
type of washing agent used have any association with net 
durability (F = 0.03, P < 0.969).
While the mean number of holes per net, the hole 
index and hole area showed an increasing trend between 
0 and 36 months, no more than 13% of holes were ever 
greater than size 2 (Tables 2, 3, 4).
Net efficacy through bioassay
Baseline cone bioassay tests on ICON Maxx and CTN 
(Iconet) after treatment but before distribution resulted 
in 100% knockdown and 100% 24-h mortality on all 
pieces tested (Figs. 2 & 3). After six months of use the 
mean percentage mortality (± 95% CI) was signifi-
cantly greater on ICON Maxx than on CTN (87.2%, CI 
82–92 vs 63.9%, CI 56–87, p < 0.0001); similarly, mean 
percentage knockdown on ICON Maxx was signifi-
cantly greater than that on the CTN (97.7%, CI 96–99 
vs 86%, CI 78–94, p < 0.004) (Figs.  2 & 3). The survey 
after 12  months of use continued to show differences 
between ICON Maxx and CTN treatments in mean 
percentage mortality (93%, CI 86–96, vs 72%, CI 62–81, 
p < 0.0004) and mean percentage knockdown (97%, CI 
94–99, vs 85%, CI 78–91, p < 0.0005) (Figs. 2 & 3). With 
respect to pass rate, 1 ICON Maxx and 8 CTN failed 
the cone after 6 months of use (Fig. 4). Some nets that 
failed the cone test subsequently passed the tunnel test 
criteria (1 ICON Maxx and 2/8 CTN), producing com-
bined test pass rates of 100% for ICON Maxx and 80% 
(24/30) for CTN at 6  months (Fig.  4, Table  5). After 
12  months of use, whilst the combined test pass rates 
remained high for ICON Maxx nets at 96.7% (29/30), 
it was much lower for the CTN at 66.7% (20/30) 
(Fig.  4, Table  5). Bioassays on the CTN were discon-
tinued forthwith. Subsequent surveys focused on the 
ICON Maxx nets. After 18 months fewer ICON Maxx 
nets passed the cone test (70%, 21/30) but combined 
cone and tunnel testing produced an overall pass rate 
of 96.7% (29/30) similar to the pass rate at 12  months 
(Fig.  4, Table  5). After 24  months the combined pass 
rate remained high at 90% (27/30). After 30  months, 
although fewer nets passed the cone test criteria (33%, 
10/30), the majority of nets that failed the cone tests 
achieved the tunnel test criterion (80%, 16/20) produc-
ing an overall pass rate of 86.7% (26/30). At 36 months, 
although only 26% (13/50) of ICON Maxx nets passed 
the cone criterion, 86.5% (32/37) of nets that failed the 
cone achieved the tunnel test criterion producing an 
overall pass rate of 90% (45/50) (Fig. 4). The incremen-
tal decrease in pass rate over the full 36  months was 
small but significant (χ2trend = 11, P = 0.001). The incre-
mental decrease in cone test pass rate was highly sig-
nificant over the full 36 months (χ2trend = 34, P = 0.001).   
Analysis of chemical content and insecticide retention 
(Fig. 5 and Table 6)
At baseline, the mean lambda-cyhalothrin content of 
ICON Maxx treated nets was 60.1 mg AI/m2 (Fig. 5a); this 
was very close to the target of 62 mg AI/m2. At baseline 
the mean lambda-cyhalothrin content among CTN was 
Table 2 Physical condition of IconMaxx and CTN by survey round holes by size category
Survey (month) ICON Maxx lambda‑cyhalothrin CTN








1 2 3 4 1 2 3 4
Cross section survey
 0 30 0 0 0 0 – 30 0 0 0 0 –
 6 30 4 58 29 13 – 30 5 44 26 30 –
 12 30 9 72 21 7 – 30 7 57 30 13 –
 24 30 14 53 36 11 – – – – – – –
 36 50 20 59 31 8 2 – – – – – –
Cohort survey
 0 264 0 0 0 0 – 266 0 0 0 0 –
 12 98 5 54 34 12 – 113 3 56 32 12 –
 24 46 11 66 25 9 – – – – – –
 36 40 15 41 50 7 2 – – – – – –
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12.7  mg AI/m2, well within the acceptable limits of the 
target dose of 15 mg AI/m2 (Fig. 5b). After 12 months of 
household use the lambda-cyhalothrin content of ICON 
Maxx had decreased to 28.9 mg AI/m2 corresponding to 
52% loss of the baseline AI content (Fig. 5a); the content 
of CTN decreased to 4  mg AI/m2 after 12  months cor-
responding to 68% of baseline AI content (Fig. 5b). After 
36 months the mean lambda-cyhalothrin content on the 
surveyed ICON Maxx nets was 15.8  mg AI/m2 (n = 50, 
RSD = 93.4%) corresponding to 73.7% loss of the original 
content (Table 6).
The mean lambda-cyhalothrin concentration on 
ICON Maxx treated nets that passed the cone bioassay 
criteria at 36  months was 30.4 (21.4–39.4) mg AI/m2, 
while content on nets that failed the cone criteria was 
10.7 (7.5–13.9) mg AI/m2; the difference in AI content 
between failing nets and those passing cone test criteria 
was significant  (F1,48 = 26.1, P = 0.0001).
The mean concentration on nets that failed the tun-
nel test criteria was 5.7 mg/m2 and on those that passed 
was 16.9  mg/m2; the difference in AI content between 
pass and fail was significant (t = 2.5, P = 0.009).
Adverse effects among staff treating nets and families 
using nets
Three attendants were responsible for treating nets at the 
start of the project at a rate of 60 nets per person per day 
for 2 weeks. All attendants who treated the nets reported 
sneezing and facial itching, and one reported fever. The 
adverse effects were more common after treating with 
Iconet (CTN) than after treating with ICON Maxx, even 
though the treatment dose was higher for ICON Maxx. 
One of the attendants regularly reported irritation to 
facial skin (paraesthesia). The effect took about 3  h to 
subside on each occasion. The discomfort was not so 
severe that the individual took time off work. All proper 
precautions were taken while treating the nets including 
wearing of masks and gloves.
Of the 60 households included in the first week and 
first month post-treatment surveys, only a small pro-
portion reported experiencing any adverse effects and 
only during the first few days of net use. Similar pro-
portions of Iconet CTN users (10%) and ICON Maxx 
net users (6%) reported these effects which included 
bad odour, sneezing, skin itching, nasal discharge 
and facial itching. The effects were transient and did 
not deter users from continuing to use the nets. No 
adverse effects were reported after one month of use. 
















ICON Maxx                                                      Iconet
Mean KD
Outliers
Fig. 2 Median (IQR) and mean percentage An. gambiae s.s. (Kisumu) knockdown 1 h post-exposure to ICON Maxx and CTN pieces in cone bioassays
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that all symptoms stopped after the net had been 
washed once. At no stage did any of the adverse events 
require medical attention.
Net attrition and survivorship rate
Net survivorship due to loss of integrity (accumu-
lated holes) caused by physical deterioration or dam-
age fell from 100 to 78% after 12  months, to 70% 















ICON Maxx                                             Iconet
Mean mortality
Outliers

























ICON Maxx                                                                     Iconet
Tunnel
Cone
Fig. 4 Percentage ICON Maxx & CTN meeting WHO efficacy criteria (solid bar = cone test, hatched bar = tunnel test) by survey round. The 
horizontal line represents the acceptability cut-off for WHOPES full approval of the LN
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Table  2b). A very high proportion of nets distributed 
(72%, 189/264) were lost not due to loss of integrity 
but to more mundane reasons such as moving house 
to outside the study area, hut collapse, or nets being 
given away during the 36 months. For most of the nets 
that were lost to follow up this occurred between 0 and 
24 months.
In the comparison of physical integrity of nets 
between the cohort-longitudinal surveys and cross-sec-
tional surveys, the majority of holes in the cohort sur-
veys were found in the lower part of the panels (Table 3 
& Fig.  7). In all three cohort surveys the hole indices 
were significantly lesser (Z = 2.46; P = 0.014 for 12th 
month, Z = 2.6; P = 0.009 for 24th month and Z = 6.14; 
P = 0.001 for  36th month surveys) than in the cross-
sectional surveys after the corresponding periods of 
use (Table 3 & Fig. 7). This may reflect cohort members’ 
self-awareness that they were being monitored more 
closely than other recipients of ICON Maxx treated 
nets.
Attrition and physical integrity of the ICON Maxx-
treated nets were monitored as recommended in the 
WHO LLIN testing guidelines. As a home-treatment 
kit, it should be noted that net integrity and hole index 
were never part of the product claim of ICON Maxx. 
Nevertheless, it was important to compare net integ-
rity and bio-efficacy as part of the evaluation of ICON 
Maxx and to correlate the formulation performance 
with polyester net condition, as well as consider other 




The present study evaluated the efficacy of ICON Maxx 
treated nets for up to 36 months of household use using 
Table 5 Percentage of ICON Maxx and Iconet CTN meeting WHO efficacy criteria by survey round
Survey 
(month)
ICON Maxx lambda‑cyhalothrin CTN
Cone bioassays Tunnel tests Cone and tunnel tests 
combined 
Cone bioassays Tunnel tests Cone and tunnel 
tests combined 
0 100 (30/30) – 100 (30/30) 100 (30/30) – 100 (30/30)
6 96.7 (29/30) 100 (1/1) 100 (30/30) 73.3 (22/30) 25 (2/8) 80 (24/30)
12 93.3 (28/30) 50.0 (1/2) 96.7 (29/30) 56.7 (17/30) 23 (3/13) 66.7 (20/30)
18 70.0 (21/30) 88.9 (8/9) 96.7 (29/30) – – –
24 70.0 (21/30) 66.7 (6/9) 90.0 (27/30) – – –
30 33.3 (10/30) 80.0 (16/20) 86.7 (26/30) – – –
























ICON Maxx                                            

































Fig. 5 a Lambda-cyhalothrin content (mg AI/m2) on individual 
IconMaxx nets samples at baseline after 12 and after 36 months of 
field usage for IconMaxx nets. Mean concentrations for each time 
point are indicated by the thin horizontal lines. The target dose and 
upper and lower limits are for lambda-cyhalothrin content at baseline 
indicated as solid and dashed lines. b Lambda-cyhalothrin content 
(mg AI/m2) on individual CTN samples at baseline after 12-monthly 
intervals of field use for Iconet. Mean concentrations for each time 
point are indicated by the thin horizontal lines. The target dose and 
upper and lower limits are for lambda-cyhalothrin content at baseline 
indicated as solid and dashed lines
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the standard WHO cone bioassay criteria of knock-
down and mortality and the tunnel test criteria of mor-
tality and blood feeding inhibition. According to WHO 
testing guidelines [13] a candidate LLIN or long-lasting 
treatment kit is deemed to meet the requisite thresh-
old for WHO recommendation if, at the end of 3 years 
use, at least 80% of the sampled nets retain bio-efficacy 
using any of the WHO bioassay criteria [13].
Applying the WHO criteria, ICON Maxx failed to 
achieve the 80% threshold at the 36-month sampling 
point on the basis of cone bioassay alone. On inclu-
sion of the tunnel test data, more than 90% of ICON 
Maxx treated nets met the efficacy criteria for the com-
bined cone test and tunnel test. While the bio-efficacy 
of ICON Maxx treated nets remained high through-
out the 36-month study period, the comparator arm of 
Iconet CTN was dropped from the trial after 12 months 
because at that sampling point it fell short of the 
required 80% pass rate and was considered unethical 
to continue. At that point, the CTN households were 
provided with ICON Maxx sachets and instruction 
leaflets and verbal guidance given.
Examining the bioassay methods individually, the 
ICON Maxx nets met the WHO cone efficacy criteria 
for the first 12 months. In the 2nd year fewer than 80% 
of nets met the WHO cone criteria, and the tunnel test 
played an increasingly important role. By the 36-month 
survey point, 74% of sampled ICON Maxx nets were 
failing the cone test and the tunnel testing was required 
to achieve the 80% pass rate. Contrast the long-lasting 
treatment kit results with other net products tested 
in Phase III trials at NIMR Muheza, such as Intercep-
tor LN [17], a factory produced long lasting insecti-
cidal net. After 36  months, a much higher proportion 
of Interceptor LN, 77% (23/30), met the cone criteria 
and only a few cone-failures needed to go forward to 
tunnel testing criteria to take Interceptor LN over the 
line. By contrast, with the ICON Maxx sampled at 
36 months only 26% (13/50) met the cone criteria and 
a further 86% (32/37) had to go forward to tunnel test-
ing to take ICON Maxx over the line. Why the differ-
ence? Was it differences in binder constituents between 
ICON Maxx and Interceptor LN or was it differences in 
binding process: factory versus community? The two-
Phase III studies were comparable: both were done at 
the NIMR Amani Centre by the same scientific group 
in consecutive years. But because the two alphacyano-
pyrethroids (alpha-cypermethrin in Interceptor LN 
and lamba-cyhalothrin in ICON Maxx) and the load-
ing dosages (200 mg/m2 in Interceptor LN and 62 mg/
m2 in ICON Maxx) were not the same in the two prod-
ucts, the differences in efficacy cannot be attributed 
with any certainty to differences in binder technology 
(factory machine versus field hand treatment) or binder 
composition. However, the proportions of loading con-
centration lost over 12 to 36  months in the field were 
in fact remarkably similar: 49% in Interceptor and 48% 
in ICON Maxx after 12  months, and 82% in Intercep-
tor and 74% in ICON Maxx after 36  months [19, 20]. 
It may not be a question of quality of binding agent or 
within-net heterogeneity between factory treatment 
versus community treatment but simply a question of 
Table 6 Lambda-cyhalothrin content (mg AI/m2) on ICON Maxx nets and CTN at baseline and after field use
Survey (month) ICON Maxx‑treated nets Iconet CTNs
N Mean %AI loss N Mean %AI loss
mg AI/m2 mg AI/m2
0 30 60.1 (56.3–63.9) – 30 12.7 (11.5–13.9) –
12 30 28.9 (23.9–33.9) 52% 30 4 (0.9–7.1) 68%






0 1 2 3
Analysis time in years
Fig. 6 Kaplan–Meier Nets Survival Curve; Hatched line = Net 
discarded due to damage, Solid line = Net discarded due to damage 
or lost to follow-up)
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different pyrethroid and the higher concentration of 
AI applied under factory conditions. Notwithstanding 
the true reason, the Tanzanian ICON Maxx samples 
did meet the bio-efficacy criteria, the overall study was 
reviewed by the WHO and ICON Maxx was given full 
recommendation as a long-lasting net treatment for up 
to 3 years of use.
Besides Tanzania, the only other significant Phase III 
trial of ICON Maxx sponsored by WHO was conducted 
in India in Odisha state [19, 21]. Relatively poorer perfor-
mance of ICON Maxx nets was reported, with only 59% 
of the ICON Maxx nets meeting efficacy criteria with the 
combined cone test or tunnel test after 36 months. While 
80% passed the combined cone-tunnel after 30 months, 
a much smaller proportion of the tested Anopheles ste-
phensi responded adequately (41% mortality in the tun-
nel after 36  months and only 17% of nets passing the 
tunnel criteria) as compared to the 81% mortality in the 
tunnel with An. gambiae after 36 months in Tanzania and 
86% of nets passing the tunnel criteria. Another differ-
ence notably at odds with the Tanzanian trial was high 
AI retention of lambda-cyhalothrin in ICON Maxx nets 
after 36  months (34  mg/m2 or 55% of loading content), 
potentially due to the shorter season of net use in India 
each year, as compared to 16  mg/m2 or 26% of loading 
content retained after 36  months and the much longer 
period of use in Tanzania. While the tunnel test is a 
highly realistic bioassay and simulator of experimental 
hut trials, there are clearly outstanding questions about 
vector responsiveness to bait in the tunnel and compara-
tive performance of the different mosquito species that 
need to be resolved.
Beyond ICON Maxx, several brands of standard LLIN 
have achieved full WHO recommendation. Among the 
polyester LLIN they include PermaNet 2.0 LN and Inter-
ceptor LN [9, 22]. Among the polyethylene LLIN they 
include Olyset LN and Duranet LN [20, 23]. A further 
four brands have obtained WHO full recommenda-
tion on the basis of equivalence to the aforementioned 
brands, and a further nine have obtained WHO interim 
recommendation after demonstrating bio-efficacy in 
Phase II experimental hut trials [24]. The main purpose 
of ICON Maxx, in having achieved full recommendation, 
is not to rival these brands of LLIN (which it could do) 
but to facilitate the treating of untreated nets, acquired 
commercially, in community or home, or for re-treating 
currently used nets between universal coverage cam-
paigns if the gap is proving too long.
As mentioned, net integrity and hole index is not part 
of the product claim. Nevertheless, as part of the evalu-
ation it was important to compare net integrity and bio-
efficacy with what owners’ report. This is particularly 
important when, as a cultural norm, the net recipients 
may not be allowed free access to the home to inspect 
the nets in  situ. For example, nets became quite dirty 
























12  24  36
Fig. 7 Comparison of median (IQR) and mean ln (hole index + 1) of the ICON Maxx nets between cohort and cross section surveys at 12-, 24- and 
36-month’s survey points
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wash them every few months. There was no association 
between the reported number of washes at 36  months 
and the proportion of nets passing the cone bioassay cri-
teria or with how much alpha-cypermethrin remained on 
the net. There was no association between the reported 
number of washes per net and net integrity (hole index). 
The only correlation observed was between the reported 
frequency of net use and net integrity or hole index. 
Clearly the hole index is a key indicator to retain with 
longitudinal studies of this kind. The positive association 
between bioassay outcome and AI content was reassur-
ing to observe, as was the association between hole index 
and loss of bioassay efficacy or loss of AI content over 
time. Net cleanliness and reported number of washes 
were not reliable. The respondents may for personal rea-
sons feel bound to give responses which they think will 
encourage the interviewer even when this is not the aim; 
for example, they may wish to report relatively higher 
number of washes with the purpose of showing that 
the net is being well cared for. The study did also high-
light that washing was not the sole cause of insecticide 
removal; physical abrasion and friction during daily use 
was obviously a major factor too.
Net integrity and durability
While many LLIN brands may achieve the requisite 
WHO bio-efficacy, few LLINs can withstand the abra-
sion and wear and tear of 3  years of field use. Survival 
will depend on the local environment and conditions of 
use. After 36  months, the majority of treated nets were 
lost or damaged: 18% were without holes and most were 
dirty. The condition of the polyester nets was consistent 
with that of the factory treated polyester LLIN previously 
evaluated in the same district where only 17% were with-
out holes and 70% were dirty [17]. Both cross-sectional 
and cohort longitudinal surveys were used in monitor-
ing of net integrity and the accumulation of holes. Nets 
sampled during cross-sectional surveys were always in 
worse condition as compared to cohort nets surveyed 
at the same time point. One possible explanation is that 
cohort households were better informed from the outset 
of their involvement in the longitudinal study than were 
cross sectional households. With the insight that their 
nets would be periodically inspected, this might have 
influenced cohort households to look after their nets bet-
ter than the cross-sectional households did. Another pos-
sible reason was cultural. According to the norms of the 
society living in the study area, most householders were 
not willing to allow access to field workers to their home 
to randomly select the net for cross sectional survey. In 
most cases it was the householders who sampled the net 
to give to the field workers. Their awareness that the sam-
pled net would be replaced by a new one could influence 
them to select the net of worse condition as a way of dis-
carding a net nearer its end of life. This might have led to 
net sampling bias during cross sectional surveys leading 
to samples of worse condition compared to cohort nets.
As shown by the present trial, nets are lost to follow-up 
for a variety of reasons apart from deterioration or attri-
tion. This might include migration of trial families and 
giving away or misuse of nets. Attrition due to reasons 
other than loss of integrity is a drain on the trial in terms 
of time and resources and creates the risk of leaving the 
trial underpowered for measuring true attrition due to 
loss of integrity. In some cases, losses to follow-up may 
make up 70% of the nets distributed at the start of a trial. 
Consequently, it is desirable to devise new procedures to 
limit such losses to follow-up.
How can net retention be improved? Any form of 
coercion would be unethical and impossible to enforce 
in practice. In the current WHO LLIN trial procedures, 
participating families are under no obligation to use or 
retain their nets. However, it might be possible to specify 
terms in the participant consent form that would help 
improve net retention while not affecting participants’ 
right to withdraw at any stage of the trial. In response to 
this issue, which arose from consideration of the present 
trial, the WHO proposed modifications to the consent 
forms used in Phase III trials and suggested the following 
new procedures:
a) Cohort surveys
Study participants/families enrolled into the cohort com-
ponent of the trial would be requested to consent to the 
following:
• Participants would not give away or sell the study 
nets;
• Participants would retain the freedom to stop using 
the nets at any time but should let investigators know 
the reasons when asked during the follow-up survey;
• Investigators would inform participants that the nets 
will be replaced after 3 years (at the end of the trial 
period and not before) regardless of net condition 
but only on production of the trial net which may be 
stored in the meantime for inspection;
• If participants stop using the trial net for any reason, 
including accumulation of holes, they must store the 
net for replacement after 3  years, or give it to the 
investigators who will replace it after the 3-year trial 
period has elapsed.
Such consent by participants would fulfil the needs of 
the trial and may reduce non-attritional losses, but would 
not affect participants’ right to stop using their nets at 
any time for whatever reason.
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b) Cross‑sectional surveys
Other families who are eligible to be selected for cross-
sectional surveys would have their nets replaced at the 
time of destructive sampling and would not be eligible for 
a second substitution at the end of the trial. Their con-
sent form would be amended differently. They would be 
informed:
• That they should not give away or sell the study nets; 
and
• That they retain the freedom to stop using the nets 
at any time but are required to let investigators know 
the reasons when asked during the follow-up survey.
These were adopted by the WHO [19] and shall 
be included in the next edition of the WHO LLIN 
guidelines.
Treatment of other polymer nets and materials
While this Phase III field trial evaluated the bio-efficacy 
and wash-fastness of ICON Maxx on polyester nets, a 
parallel Phase I study assessed ICON Maxx treatments 
on netting made of cotton, polyethylene, nylon, white and 
dyed polyester. The aim was to widen the range of house-
hold materials that vector mosquitoes may encounter in 
broader range of settings, and which could be rendered 
insecticidal without having to specify target product pro-
files or create bespoke products which may not justify the 
cost of investment as specific products or interventions.
Evaluation compared WHO cone, cylinder and tunnel 
tests using An. gambiae. ICON Maxx treated polyester 
and polyethylene netting met the WHO cone and tunnel 
test bio-efficacy criteria for LLIN after 20 standardized 
washes, and nylon and cotton netting passed the WHO 
tunnel test criterion of 80% mortality after 20 washes. 
The correlation of these findings with the current Phase 
III data on polyester raises the prospect of using ICON 
Maxx as an effective approach for converting untreated 
nets, curtains, military clothing, blankets, top-sheets and 
tents and tarpaulins, as used in disasters and humanitar-
ian emergencies, into effective long-lasting insecticidal 
products for vector control of malaria [25–27], leishma-
niasis [28] and dengue [29]. It may also provide a solu-
tion to the problem of reduced LLIN coverage between 
universal coverage campaigns by enabling conversion of 
commercially sourced untreated polyester and polyeth-
ylene nets into LLINs via community treatment. It may 
also prise open a new door to binding of non-pyrethroid 
insecticides to nets and textile materials for control of 
pyrethroid resistant vectors.
Conclusion
This WHO Phase III household randomized trial of 
ICON Maxx treated polyester nets conducted in Tanza-
nia achieved the combined cone and tunnel test efficacy 
criteria after 36 months of use. On the basis of this and 
other trials, and noting the overall bio-efficacy of the 
ICON Maxx long-lasting treatment for polyester nets, 
full recommendation was granted with an estimated 
duration of insecticidal efficacy of 36 months depending 
on the local setting. To guarantee efficacy, ensure proper 
net treatment and to minimize losses to reasons other 
than physical integrity, health education leaflets and 
packages should be provided concurrently with ICON 
Maxx sachet distribution.
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